共 126 条
[1]
Reddy MS(2017)Revisiting APOLT for metabolic liver disease: a new look at an old idea Transplantation 101 260-266
[2]
Rajalingam R(2013)Monogenic diseases that can be cured by liver transplantation J Hepatol 59 595-612
[3]
Rela M(2017)Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation Pediatr Transplant 54 2382-2386
[4]
Fagiuoli S(2019)Feasibility and safety of using low-body-weight donors in pediatric liver transplantation J Pediatr Surg 1 118-120
[5]
Daina E(2011)Auxiliary liver transplantation: a form of gene therapy in selective metabolic disorders J Clin Exp Hepatol 83 1405-1406
[6]
D'Antiga L(2007)Reciprocal auxiliary partial liver transplant for inborn noncirrhotic metabolic diseases Transplantation 229 565-569
[7]
Colledan M(1999)Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I Ann Surg 62 417-428
[8]
Remuzzi G(2015)Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system Hepatology 11 1332-1342
[9]
Dong C(2005)Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University Liver Transpl 20 817-824
[10]
Gao W(2020)Application of pediatric donors in split liver transplantation: Is there an age limit? Am J Transplant 52 157-160